TYROSINE KINASE INHIBITORS in MANAGEMENT of AGGRESSIVE DIFFERENTIATED THYROID CANCER - Softcover

De Groot MD, Leslie J; Hennessey MD, James V

Softcover

ISBN 10: 1499618719 ISBN 13: 9781499618716

Publisher: CreateSpace Independent Publishing Platform, 2014

Synopsis

This small book offers up to the minute information on a serious medical problem- management of differentiated thyroid cancer no longer amendable to surgery or RAI. It covers contemporary initial diagnosis and treatment, making an evidence based decision to move beyond RAI therapy, detailed and practical information on use of tyrosine kinase targeted treatment, and a look at what may come after single-agent TKIs. The authors are all steeped in management of thyroid cancer, including Furio Pacini and Leslie De Groot, Martin Schlumberger, Michael Tuttle and Monica Sabra, Joshua Klopper and Brian Haugen, James Fagin, and James Hennesey. The symposium is presented by www.Thyroidmanager.org and www.Endotext.org, in which pages it was initially published.

About this title

About the Author:

James C Hennessey,MD is a graduate in medicine of University of Graz, Austria, and completed his training in Endocrinology at Walter Reed Army Medical Center. He served on the faculty at Brown Medical School from 1993 to 2007, and is now Associate Professor at Harvard Medical School and Director of Clinical Endocrinology at Beth Israel Deaconess Medical Center. Leslie J De Groot, MD graduated from Columbia Medical School, spent 12 years in the Thyroid Unit at Mass General Hospital, and several decades at University of Chicago. He is currently Emeritus from Chicago, and Research Professor at University of Rhode Island. He edits the web-books WWW.THYROIDMANAGER.ORG and WWW.ENDOTEXT.ORG, and co-edits "ENDOCRIOLOGY".

About this edition

• Publisher: CreateSpace Independent Publishing Platform
• Publication date: 2014
• ISBN 10: 1499618719
• ISBN 13: 9781499618716
• Binding: Paperback
• Number of pages: 80